First Trust Nasdaq Pharmaceuticals ETF Rating $26.30 +0.01 (+0.02%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.58Holdings in FTXH have an aggregate rating of Moderate Buy based on 757 analyst ratings issued in the past year covering 49 companies (99.5% of the portfolio).FTXH Aggregate Price Target$26.31High Prediction$26.31Average Prediction$26.31Low Prediction$26.31Holdings in FTXH have an aggregate price target of $26.31 and a range of $26.31 to $26.31 covering 49 companies (99.5% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.43%JNJJohnson & Johnson$155.90+0.2%4.8506 of 5 stars2.55$170.88 9.6%20Positive News7.36%PFEPfizer$25.45+0.5%4.976 of 5 stars2.45$28.55 12.2%22Trending News7.01%ABBVAbbVie$189.50-0.7%4.9062 of 5 stars2.81$211.29 11.5%27Trending NewsAnalyst Revision6.89%MRKMerck & Co., Inc.$80.97-1.7%4.9963 of 5 stars2.43$109.19 34.8%21Positive News6.25%BMYBristol Myers Squibb$47.02-1.3%4.9279 of 5 stars2.32$58.00 23.4%22Positive News3.92%VTRSViatris$9.25-1.0%3.3111 of 5 stars1.80$10.40 12.4%53.89%GILDGilead Sciences$111.28-0.2%4.8455 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade3.75%ZTSZoetis$159.19+0.1%4.8386 of 5 stars3.00$212.13 33.3%10Positive News3.62%AMGNAmgen$298.25+0.5%4.5254 of 5 stars2.35$307.82 3.2%233.61%BIIBBiogen$132.63-0.4%4.9332 of 5 stars2.38$188.48 42.1%323.57%UTHRUnited Therapeutics$294.57-0.2%4.9955 of 5 stars2.69$386.15 31.1%13Positive News3.39%LLYEli Lilly and Company$779.60+0.0%4.9865 of 5 stars2.75$1,011.61 29.8%20Trending News3.00%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9241 of 5 stars2.80$813.57 49.3%252.99%JAZZJazz Pharmaceuticals$109.45-0.4%4.9309 of 5 stars2.92$184.00 68.1%13Positive NewsInsider Trade2.40%EXELExelixis$45.91+3.6%4.7504 of 5 stars2.52$43.56 -5.1%21Trending NewsAnalyst RevisionHigh Trading Volume2.35%ELANElanco Animal Health$14.64-0.5%2.2611 of 5 stars2.50$15.33 4.7%8Analyst Forecast2.09%CRLCharles River Laboratories International$157.12-0.2%4.066 of 5 stars2.19$171.85 9.4%16Positive News1.99%ILMNIllumina$100.44+0.1%4.907 of 5 stars2.47$127.39 26.8%19Positive News1.92%OGNOrganon & Co.$10.08-0.7%4.8273 of 5 stars2.50$18.00 78.7%6Trending News1.90%MEDPMedpace$321.50-1.4%4.463 of 5 stars2.21$344.82 7.3%141.59%NBIXNeurocrine Biosciences$128.04-1.1%4.9183 of 5 stars2.86$162.00 26.5%22Positive News1.33%HALOHalozyme Therapeutics$54.05+0.4%4.852 of 5 stars2.17$61.90 14.5%121.09%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9437 of 5 stars2.75$93.61 63.5%24Analyst Forecast1.03%ALKSAlkermes$28.75-0.9%4.9362 of 5 stars2.83$40.00 39.1%12Positive NewsAnalyst Revision0.97%PRGOPerrigo$27.20-0.2%4.8762 of 5 stars2.25$33.00 21.3%40.87%AMRXAmneal Pharmaceuticals$8.56+2.3%3.2239 of 5 stars3.00$11.60 35.5%50.80%PBHPrestige Consumer Healthcare$79.98-0.2%4.2408 of 5 stars2.50$93.33 16.7%6Positive News0.73%BPMCBlueprint Medicines$128.27+0.1%1.7442 of 5 stars2.27$128.06 -0.2%220.72%CAHCardinal Health$164.80+1.7%4.8215 of 5 stars2.79$157.43 -4.5%14Positive NewsEx-DividendAnalyst Revision0.72%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3183 of 5 stars2.79$340.00 2.4%24Positive News0.72%CPRXCatalyst Pharmaceuticals$21.64+0.9%4.9251 of 5 stars3.25$32.83 51.7%80.68%TGTXTG Therapeutics$37.20+2.5%3.1747 of 5 stars2.80$40.80 9.7%50.68%INSMInsmed$98.50+0.3%4.1675 of 5 stars3.00$106.80 8.4%17Positive News0.67%CORTCorcept Therapeutics$72.65+1.8%4.7575 of 5 stars3.00$138.25 90.3%5News Coverage0.66%GHGuardant Health$50.25+0.1%3.7629 of 5 stars3.00$53.76 7.0%21Insider Trade0.63%EXASExact Sciences$52.82-1.9%4.9205 of 5 stars2.95$70.40 33.3%22Positive NewsAnalyst Revision0.63%ACADACADIA Pharmaceuticals$20.95-1.4%4.6936 of 5 stars2.71$27.88 33.1%170.63%AKROAkero Therapeutics$52.01+0.3%3.5803 of 5 stars3.00$82.50 58.6%6Insider Trade0.61%ADMAADMA Biologics$18.30+0.9%4.2175 of 5 stars3.33$27.67 51.2%30.52%INCYIncyte$68.46+0.4%4.3504 of 5 stars2.22$74.53 8.9%180.51%SRRKScholar Rock$35.35-0.6%3.8879 of 5 stars3.14$42.67 20.7%70.51%VRTXVertex Pharmaceuticals$454.64-0.5%4.7261 of 5 stars2.54$511.62 12.5%28Positive News0.50%PTCTPTC Therapeutics$48.77-0.8%4.3243 of 5 stars2.67$65.00 33.3%15Analyst Revision0.49%MDGLMadrigal Pharmaceuticals$298.49-0.6%4.1117 of 5 stars2.89$420.63 40.9%90.45%VCELVericel$41.79+0.8%2.946 of 5 stars3.00$61.14 46.3%7Positive News0.45%AXSMAxsome Therapeutics$105.36+1.4%4.7015 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision0.44%VCYTVeracyte$27.51-0.3%3.619 of 5 stars2.70$40.90 48.7%100.43%KRYSKrystal Biotech$143.01+1.2%4.5962 of 5 stars3.00$211.13 47.6%9News CoverageAnalyst Revision0.09%SRPTSarepta Therapeutics$18.22+0.1%4.7373 of 5 stars2.44$60.88 234.2%25Trending News This page (NASDAQ:FTXH) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts